Ontology highlight
ABSTRACT:
SUBMITTER: Dai Y
PROVIDER: S-EPMC3813138 | biostudies-literature | 2012
REPOSITORIES: biostudies-literature
Iranian journal of pharmaceutical research : IJPR 20120101 3
The inhibitors of p53-HDM2 interaction are attractive molecules for the treatment of wild-type p53 tumors. In order to search more potent HDM2 inhibitors, docking operation with CDOCKER protocol in Discovery Studio 2.1 (DS2.1) and multidimensional hybrid quantitative structure-activity relationship (QSAR) studies through the physiochemical properties obtained from DS2.1 and E-Dragon 1.0 as descriptors, have been performed on 59 1,4-benzodiazepine- 2,5-diones which have p53-HDM2 interaction inhib ...[more]